Which is better, ABBV or SLNO?

On the Buffett-Fit framework, AbbVie Inc. (ABBV) currently grades higher than SLNO, 49/100 (D grade) vs 50/100 (C). That said, "better" depends on which framework you trust, ABBV wins on Benjamin Graham, Philip Fisher, Joel Greenblatt, Charlie Munger, and Terry Smith; SLNO wins on Warren Buffett and Peter Lynch. The full pillar breakdown is on this page.

Should I buy ABBV or SLNO?

This page is an educational comparison, not investment advice. Both ABBV and SLNO are graded against the same Buffett 5-pillar framework (moat, earnings durability, management quality, financial health, valuation) plus six other documented investor frameworks. Read the side-by-side breakdown to see which one matches the criteria you care about most, and always do your own research before making any investment decision.

Is ABBV better than SLNO for value investing?

The two are close on the headline Buffett-Fit score (49/100 vs 50/100), so "better for value investing" depends on which pillar you weight most. The five Buffett pillars + six other frameworks are broken down side-by-side on this page so you can pick the one that fits your style.

What's the difference between ABBV and SLNO on Warren Buffett's framework?

Both stocks are evaluated on the same five pillars: economic moat (durable competitive advantage), earnings durability (consistent profitability), management quality (capital allocation), financial health (conservative balance sheet), and valuation (margin of safety). ABBV currently scores 49/100; SLNO scores 50/100. The "Where each wins" section on this page breaks down which pillar each stock dominates.

Which has the stronger moat, ABBV or SLNO?

Moat strength is one of the five pillars in the Buffett-Fit score on this page. ABBV and SLNO are each scored on ROIC sustainability, gross-margin durability, and qualitative signals like brand strength, switching costs, network effects, and regulatory barriers. The pillar breakdown on this page shows the moat sub-score side-by-side so you can see which one has the more durable competitive advantage.

Which is more undervalued, ABBV or SLNO?

Valuation is one of the five Buffett-Fit pillars on this page. Both stocks are scored on owner-earnings yield, price-to-intrinsic-value vs the underlying compounding rate, and the margin of safety relative to a conservative DCF. The valuation sub-score in the table below tells you which one currently trades at a more attractive price relative to its underlying business quality.

Are ABBV and SLNO both Healthcare stocks?

Yes: both AbbVie Inc. (ABBV) and Soleno Therapeutics, Inc. (SLNO) operate in the Healthcare sector. That makes this a direct sector-peer comparison, which is the apples-to-apples way to use the Buffett-Fit framework: the score weighs each stock against its sector's specific quality and valuation benchmarks (sector-relative bonus), so the cross-stock comparison isn't distorted by inter-sector base-rate differences.

Is this ABBV vs SLNO comparison investment advice?

No. This page is an educational pattern-match against documented public frameworks (Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, Smith), not personalised investment advice. The scores reflect how closely each stock matches each framework's documented criteria: they are not buy/hold/sell recommendations. Always do your own research and consult a licensed financial adviser for personalised advice.

ABBV vs SLNO: Side-by-Side Buffett Comparison · invest-like

Stock comparison

AbbVie

ABBV$506.7BHealthcare Market cap, Sector

Soleno Therapeutics

SLNO-Healthcare Market cap, Sector

Overall winner

AbbVie

ABBV 52 SLNO

Based on the combined fit scores from all four strategies. The breakdown by strategy is below.

Fit scores by strategy

ABBV5wins

2winsSLNO

Warren Buffett

49D

D50

Benjamin Graham

73B

D50

Philip Fisher

55D

D50

Peter Lynch

15F

D50

Joel Greenblatt

51D

D50

Charlie Munger

62C

D50

Terry Smith

54D

D50

Side-by-side metrics

Metric	ABBV	SLNO
Market cap	$506.7B	-
P/E (TTM)	102.5x	-
EV/EBIT	52.2x	-
ROIC (TTM)	11.97%	-
Gross margin

More like ABBV

ABBV vs LLY ABBV vs JNJ ABBV vs RO.SW ABBV vs UNH

More like SLNO

SLNO vs LLY SLNO vs JNJ

Related on invest-like

Strongest Moat Highest ROIC Warren Buffett strategy Economic Moat

For education only. Fit scores apply each investor's published criteria to public financial data. They are not personal recommendations.

See the full analysis of AbbVie vs Soleno Therapeutics

The score, the checklist and the full reasoning open with a free account. You get 3 full analyses a week, and this stock is the first one. No card needed.

Create a free account

3 full analyses a week · no card needed

Already have an account? Sign in

See the full analysis of AbbVie vs Soleno Therapeutics

Key terms in this analysis